Hu, V., Macleod, D., Weiss, H. A., Burton, M. J., Arunga, S., Leck, A., . . . Matayan, E. Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: Rationale and design of a randomised controlled non-inferiority trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationHu, Victor, et al. Topical Chlorhexidine 0.2% Versus Topical Natamycin 5% for Fungal Keratitis in Nepal: Rationale and Design of a Randomised Controlled Non-inferiority Trial. BMJ Publishing Group.
MLA (9th ed.) CitationHu, Victor, et al. Topical Chlorhexidine 0.2% Versus Topical Natamycin 5% for Fungal Keratitis in Nepal: Rationale and Design of a Randomised Controlled Non-inferiority Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.